EGFR and glioblastoma: A panel of 106 NS derived from primary GBM underwent analysis of the most frequent GBM genetic alterations such as EGFR amplification (EGFRamp), PTEN inactivation by deletion or mutation (PTENloss), TP53 mutation, and NFKBIA deletion.